The gut microbiota plays a critical role in the modulation of host metabolism and immune response, and its impairment has been implicated in many gastrointestinal and extraintestinal diseases. Current evidence shows the well-documented role of A. muciniphila in maintaining the integrity of the intestinal barrier, modulating the host immune response, and improving several metabolic pathways, making it a key element in the pathogenesis of several human diseases. In this scenario, A. muciniphila is the most promising next-generation probiotic and one of the first microbial species suitable for specific clinical use when compared with traditional probiotics. Further studies are needed to provide more accurate insight into its mechanisms of action and to better elucidate its properties in several major areas, paving the way for a more integrated and personalized therapeutic approach that finally makes the most of our knowledge of the gut microbiota.

Pellegrino, A. A., Coppola, G., Santopaolo, F., Gasbarrini, A., Ponziani, F. R., Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties, <<NUTRIENTS>>, N/A; 15 (8): 1815-N/A. [doi:10.3390/nu15081815] [https://hdl.handle.net/10807/240221]

Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties

Pellegrino, Antonio Agostino;Coppola, Gaetano;Santopaolo, Francesco;Gasbarrini, Antonio;Ponziani, Francesca Romana
2023

Abstract

The gut microbiota plays a critical role in the modulation of host metabolism and immune response, and its impairment has been implicated in many gastrointestinal and extraintestinal diseases. Current evidence shows the well-documented role of A. muciniphila in maintaining the integrity of the intestinal barrier, modulating the host immune response, and improving several metabolic pathways, making it a key element in the pathogenesis of several human diseases. In this scenario, A. muciniphila is the most promising next-generation probiotic and one of the first microbial species suitable for specific clinical use when compared with traditional probiotics. Further studies are needed to provide more accurate insight into its mechanisms of action and to better elucidate its properties in several major areas, paving the way for a more integrated and personalized therapeutic approach that finally makes the most of our knowledge of the gut microbiota.
2023
Inglese
Pellegrino, A. A., Coppola, G., Santopaolo, F., Gasbarrini, A., Ponziani, F. R., Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties, <<NUTRIENTS>>, N/A; 15 (8): 1815-N/A. [doi:10.3390/nu15081815] [https://hdl.handle.net/10807/240221]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/240221
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
social impact